You have 9 free searches left this month | for more free features.

Tofacitinib

Showing 1 - 25 of 215

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Trial (Tofacitinib 5 MG)

Not yet recruiting
  • Glioblastoma
  • Tofacitinib 5 MG
  • (no location specified)
Jul 1, 2022

Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)

Completed
  • Sarcoidosis, Pulmonary
  • +2 more
  • Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
  • +5 more
  • Portland, Oregon
    Oregon Health & Science University
Dec 3, 2021

Alopecia Areata Trial in Bangkok (Tofacitinib)

Completed
  • Alopecia Areata
  • Tofacitinib
  • Bangkok, Thailand
    Institute of Dermatology
Mar 28, 2022

Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)

Not yet recruiting
  • Vitiligo
  • Effect of Drug
  • JAK-2 inhibitor
  • Topical corticosteroid
  • (no location specified)
Mar 19, 2022

Healthy Subjects Trial in Québec (Tofacitinib Citrate)

Completed
  • Healthy Subjects
  • Tofacitinib Citrate
  • Québec, Canada
    Syneos Health Facility
Nov 25, 2021

Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Interstitial Lung Disease
  • Tofacitinib
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
Apr 4, 2022

Tofacitinib on Ulcerative Colitis Associated Spondyloarthropathy

Recruiting
  • Ulcerative Colitis
  • Spondyloarthropathy
  • Tofacitinib
  • Palermo, Italy
    IBD Unit, Department of Internal Medicine, "Villa Sofia-Cervello
Jun 21, 2022

Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)

Recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus
  • Tofacitinib
  • Ann Arbor, Michigan
    University of Michigan Health System: Department of Internal Med
May 2, 2022

Atopic Dermatitis Trial (Tofacitinib Citrate, ointment)

Not yet recruiting
  • Atopic Dermatitis
  • Tofacitinib Citrate
  • placebo ointment
  • (no location specified)
Aug 2, 2022

Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

Recruiting
  • Primary Sjögren's Syndrome
  • Tofacitinib
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022

TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular

Completed
  • Rheumatoid Arthritis
  • Tofacitinib
  • TNF Inhibitor
  • Boston, Massachusetts
    Brigham And Women's Hospital
Mar 1, 2022

Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

Recruiting
  • Immune-Mediated Colitis
  • Tofacitinib 10 mg
  • Montreal, Quebec, Canada
    Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022

COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)

Terminated
  • COVID-19 Pneumonia
  • Tofacitinib 10 mg
  • Placebo
  • New Haven, Connecticut
    Yale New Haven Health System
Mar 16, 2022

TNFi as Monotherapy or Combination Therapy With MTX and Compare

Completed
  • Rheumatoid Arthritis
  • patterns of use of combination therapy and monotherapy
  • New York, New York
    Pfizer
Oct 7, 2022

Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)

Recruiting
  • Sjogren's Syndrome
  • tofacitinib
  • Placebo
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Tofacitinib After Use Of Rituximab In Rheumatoid Arthritis In A

Not yet recruiting
  • Arthritis, Rheumatoid
    • Casablanca, Morocco
      Pfizer
    Aug 2, 2022

    Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)

    Terminated
    • Discoid Lupus Erythematosus
    • Systemic Lupus Erythematosus
    • Tofacitinib citrate
    • Boston, Massachusetts
      Tufts Medical Center
    Jan 6, 2022

    Tofacitinib PsA Initiators in the CorEvitas SpA Registry

    Active, not recruiting
    • Psoriatic Arthritis
      • New York, New York
        Pfizer
      Feb 8, 2022

      Tofacitinib on Body Composition, Bone Mineral Density and Bone

      Suspended
      • Rheumatoid Arthritis
      • Tofacitinib
      • Lille, France
        Lille University Hospital
      Feb 7, 2022

      Rheumatoid Arthritis Trial in China (Tofacitinib, Glucocorticoid)

      Recruiting
      • Rheumatoid Arthritis
      • Changxing, China
      • +4 more
      Nov 3, 2022

      Takayasu Arteritis Trial in Shanghai (Tofacitinib, Methotrexate)

      Recruiting
      • Takayasu Arteritis
      • Shanghai, Shanghai, China
        Lindi Jiang
      Oct 19, 2021

      Finland Treated With Tofacitinib for Treatment of Ulcerative

      Active, not recruiting
      • Ulcerative Colitis
        • Helsinki, Finland
          Pfizer
        Jul 10, 2022

        ANCA Associated Vasculitis, Drug Use, JAK-STAT Pathway Deregulation Trial in Shanghai (Tofacitinib)

        Completed
        • ANCA Associated Vasculitis
        • +2 more
        • Tofacitinib
        • Shanghai, Shanghai, China
          Department of Rheumatology in Zhongshan hospital, Fudan Universi
        Jul 20, 2021

        Ulcerative Colitis Trial in Chapel Hill

        Enrolling by invitation
        • Ulcerative Colitis
          • Chapel Hill, North Carolina
            Division of Gastroenterology and Hepatology
          Feb 21, 2022

          Myasthenia Gravis, Generalized Trial in Shanghai (Tofacitinib 5 MG)

          Recruiting
          • Myasthenia Gravis, Generalized
          • Tofacitinib 5 MG
          • Shanghai, China
            Huashan Hospital
          Aug 15, 2021